A study of test product setrusumab in adults with brittle bone syndrome.
A Phase 2b, Multicentre, Multinational, Double-blind, Dose-finding Study, incorporating an open label substudy, in Adult Patients with Type I, III or IV Osteogenesis Imperfecta Treated with setrusumab (BPS804). A Phase 2b, Multicentre, Multinational, Double-blind, Dose-finding Study, incorporating an open labe ...
A study of test product setrusumab in adults with brittle bone syndrome.
A Phase 2b, Multicentre, Multinational, Double-blind, Dose-finding Study, incorporating an open label substudy, in Adult Patients with Type I, III or IV Osteogenesis Imperfecta Treated with setrusumab (BPS804). A Phase 2b, Multicentre, Multinational, Double-blind, Dose-finding Study, incorporating an open labe ...